QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

21,066 signal articles · 543 in last 24h · 103,602 total before filter · latest 10m ago
543last 24h
2521last 7d
483● bullish (7d)
259● bearish (7d)
197publishers
AllMacro247Earnings1481M&A141Regulatory16Product4Analyst30
✕ clear all filtersticker: LCIDSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Lucid Group Q2 Earnings Call Highlights
MarketBeat16h agoneutral
Lucid Group Q2 Earnings Call Highlights

Lucid Group (NASDAQ:LCID) outlined a broad operational reset during its second-quarter 2026 earnings call, with newly appointed CEO Silvio Napoli saying the electric-vehicle maker is targeting approximately $1.4 billion in cash-flow improvements this year while reducing production, lowering inventor

Citi Cuts Lucid Price Target to $14: Q1 Miss, Pulled Guidance Test the Saudi-Backed EV Maker
24/7 Wall St.82d agobearish
Citi Cuts Lucid Price Target to $14: Q1 Miss, Pulled Guidance Test the Saudi-Backed EV Maker

Citi just trimmed its price target on Lucid Group (NASDAQ:LCID) to $14 from $17, while keeping a Buy rating. Analyst Michael Ward cited the company’s Q1 2026 miss and the withdrawal of its 2026 outlook, but argued the medium-term thesis remains intact. For long-term investors, the price target cut reads as a sobering near-term recalibration ... Citi Cuts Lucid Price Target to $14: Q1 Miss, Pulled Guidance Test the Saudi-Backed EV Maker

5 Insightful Analyst Questions From Lucid’s Q1 Earnings Call
StockStory82d agoneutral
5 Insightful Analyst Questions From Lucid’s Q1 Earnings Call

Lucid’s first quarter results were met with a negative market reaction as the company’s revenue and adjusted EPS both fell short of Wall Street expectations. Management attributed the underperformance to a temporary disruption in deliveries stemming from a stop sale of its Gravity model, which caused finished vehicles to sit in inventory rather than convert to revenue. Interim CEO Marc Winterhoff acknowledged, “We were hit with an unforeseen operational disruption in Q1, which we solved and deli

Lucid Diagnostics Q1 Earnings Call Highlights
MarketBeat82d agoneutral
Lucid Diagnostics Q1 Earnings Call Highlights

Lucid Diagnostics (NASDAQ:LUCD) reported first-quarter 2026 EsoGuard test volume above its pre-Medicare target range, while management said it continues to await a Medicare local coverage determination and is expanding efforts with the Department of Veterans Affairs, commercial payers and health sys